DIABETIC HYPERTENSION: STRATEGIC FOCUS - DATAMONITOR - 2002/02/18 - TF Market Research

Report title: DIABETIC HYPERTENSION: STRATEGIC FOCUS

from TF Market Research
11 page report published Feb 18, 2002

Price $440.00 available for immediate download
This report is also available for purchase on a per-page basis.

Report Overview

Purchase by Section

About TF Market Research

Source:

DATAMONITOR

Geographic Region:

INTERNATIONAL

Industries:

BIOTECHNOLOGY, HEALTH CARE, PHARMACEUTICALS

Product:

DIABETES DRUGS

Subjects:

COMPANY ANALYSES, MARKET SIZE/DEMOGRAPHICS, INDUSTRY OVERVIEW/OUTLOOK, LINES OF BUSINESS/PRODUCTS

Format:

PDF

Sections
	Title	Starting Page	Number of Pages
	1.1 COMMERCIAL IMPLICATIONS AND RECOMMENDATIONS	1	5
	1.1 COMMERCIAL IMPLICATIONS AND RECOMMENDATIONS	1	5
	NOVARTIS	5	1
	NOVARTIS	6	1
	The Navigator trial	5	1
	The Navigator trial	6	1
	Expanding patient potential through early intervention	5	2
	Expanding patient potential through early intervention	6	2
	Implications for Diovan and Starlix	6	1
	Implications for Diovan and Starlix	7	1
	AVENTIS	6	1
	AVENTIS	8	1
	Ramipril for the prevention of diabetes	6	1
	Ramipril for the prevention of diabetes	8	1
	GLAXOSMITHKLINE	6	1
	GLAXOSMITHKLINE	9	1
	Avandia (rosiglitazone) for the prevention of	7	1
	Avandia (rosiglitazone) for the prevention of cardiovascular disease	9	1
	1.3 FURTHER OPPORTUNITIES	7	2
	1.3 FURTHER OPPORTUNITIES	10	2

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

Price: $440.00

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Get FREE Research

Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.